⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLYM News
Climb Bio, Inc. Common Stock
Form 8-K
sec.gov
CLYM
Climb Bio and Mabworks Announce CLYM116/MIL116 Data Demonstrating Deep, Durable APRIL Suppression and ~70% Gd-IgA1 Reduction at ASN Kidney Week 2026
globenewswire.com
CLYM
Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug
globenewswire.com
CLYM
Form 8-K
sec.gov
QNCX
GSK
AZN
ZYME
TNYA
NTAP
EXEL
NVS
KLRS
NKTX
CLYM
INSM
Form 8-K
sec.gov
CLYM
Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy
globenewswire.com
CLYM
Climb Bio to Present at Upcoming Investor Conferences
globenewswire.com
CLYM
Form 8-K
sec.gov
CLYM
Form 8-K
sec.gov
CLYM
Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
CLYM